W8MD Weight Loss, Sleep & MedSpa

W8MD Weight Loss, Sleep & MedSpa in Brooklyn, NY operates under the medical direction of Dr. Prab R. Tumpati, a board-certified physician in obesity medicine and sleep medicine. The clinic addresses the interconnected nature of metabolic health, sleep disorders, and body composition through physician-supervised protocols that include peptide-based GLP-1 receptor agonists such as semaglutide and tirzepatide. Dr. Tumpati's dual certification allows the practice to evaluate how sleep apnea, insomnia, and circadian rhythm disorders impact weight regulation and metabolic function, creating treatment plans that address both conditions simultaneously rather than in isolation.

W8MD Weight Loss, Sleep & MedSpa's peptide therapy menu includes Liraglutide, Semaglutide, and Tirzepatide, with treatment protocols customized based on individual health goals and lab work. Additional peptide options may be available based on medical necessity and FDA guidelines.

Beyond GLP-1 therapies, W8MD incorporates sleep medicine diagnostics including home sleep apnea testing and polysomnography interpretation when clinically indicated. Dr. Tumpati evaluates how untreated sleep disorders contribute to weight gain through disrupted leptin and ghrelin signaling, elevated cortisol, and impaired glucose metabolism. Patients with confirmed obstructive sleep apnea receive CPAP titration or oral appliance therapy coordinated with their metabolic treatment plan, as improving sleep quality often enhances weight loss outcomes and energy levels. The clinic also offers aesthetic treatments through its medspa division, including body contouring procedures that complement fat loss achieved through peptide therapy and nutritional intervention.

New patients at W8MD in Brooklyn undergo an initial consultation with Dr. Tumpati that includes medical history review, current medication assessment, and discussion of weight loss goals with realistic timelines. The physician evaluates contraindications for GLP-1 peptides such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastroparesis. Baseline laboratory work is ordered to assess kidney function, liver enzymes, and pancreatic health before initiating therapy. Patients typically start on low doses of semaglutide (0.25 mg weekly) or tirzepatide (2.5 mg weekly) with gradual titration every four weeks based on tolerance and weight loss velocity. Follow-up visits occur monthly during the initial phase to monitor for side effects such as nausea, constipation, or gallbladder issues, with dosage adjustments made to optimize efficacy while minimizing gastrointestinal symptoms. The clinic provides specific dietary protocols emphasizing whole food protein sources, fiber intake for satiety, and hydration strategies to manage common peptide therapy side effects.

W8MD's Brooklyn location serves patients throughout Kings County and the greater New York City area, with evening and weekend appointment availability to accommodate working professionals. The practice maintains a 4.7-star rating across 52 Google reviews, with patients frequently noting the physician-led approach, insurance acceptance for medical visits, and structured treatment plans that extend beyond medication alone. Dr. Tumpati's background in both obesity medicine and sleep disorders creates a clinical model where metabolic dysfunction is addressed through multiple physiological pathways rather than relying solely on appetite suppression. For patients seeking peptide therapy integrated with sleep optimization and body composition monitoring under board-certified medical supervision, W8MD offers a comprehensive alternative to standalone weight loss clinics or aesthetic practices without physician oversight.